Kenneth J. Bloom

Dr. Bloom has more than 30 years of clinical and business experience and has been an early adopter and big proponent of information technology to revolutionize pathology and other areas of medicine. He is also a prolific and renowned researcher and lecturer in pathology, cancer, telemedicine, and informatics.

Came to Invicro and Ambry Genetics as Chief Medical Officer of Advanced Pathology and Genomic Services in 2018 from a position at Human Longevity, Inc, as Head Oncology and Immunotherapy Program. Before that he GE Healthcare in a position as Chief Medical Officer, In Vitro Diagnostics, Life Sciences. where he was since 2011. There he had oversight of Medical Affairs, Clinical Pathology Services, Pharma Pathology Services, Bioinformatics and Research and Development. He was also President and CEO of Clarient Pathology Services, the professional group contracted to provide pathology services to Clarient Diagnostic Services and SeqWright. In these roles he led the overall development and execution of the medical and scientific strategy, aligning them with the overall GE mission and business strategy. Prior to Clarient, Dr. Bloom was with US Labs where he was Senior Medical Director since 2002.

In addition to Dr. Bloom’s extensive business experience, he has held a series of impressive academic medical posts including Clinical Professor of Pathology at University of Southern California, Keck School of Medicine, and Associate Professor of Pathology at Rush Medical College. During the last 15 years he has held more than 10 appointed positions at Rush Presbyterian-St. Luke’s Medical Center, one of the leading cancer research hospitals in the United States, including Director of Laboratory Operations, Director of Immunohistochemistry, and Director of Information Services for Rush Cancer Center.